Overview of systematic reviews and meta-analysis of risperidone on cardiovascular risk: analysis of Cochrane and non-Cochrane systematic reviews including 11,949 patients.
Gianini Sílvia, Gianini Igor, Porto Andrey A, +5 more·International journal of psychiatry in clinical practice
OBJECTIVE: To evaluate the effects of risperidone on cardiovascular risk. METHOD: The searches were completed by means of EMBASE, MEDLINE/PubMed (by the National Library of Medicine), Scopus, and Web of Science databases. We included SRs of risperidone and cardiovascular risk published up to 2022. PRISMA was enforced…